10x Genomics (NASDAQ:TXG) reported its Q4 earnings results on Wednesday, February 16, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
10x Genomics missed estimated earnings by 77.78%, reporting an EPS of $-0.16 versus an estimate of $-0.09.
Revenue was up $31.31 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.05, which was followed by a 11.23% increase in the share price the next day.
Here's a look at 10x Genomics's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.20 | -0.26 | -0.27 | -0.23 |
| EPS Actual | -0.15 | -0.10 | -0.11 | -0.08 |
| Revenue Estimate | 122.62M | 112.85M | 102.51M | 100.40M |
| Revenue Actual | 125.30M | 115.84M | 105.82M | 112.22M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
